Global Seasonal Influenza Vaccines Market Insights and Forecast to 2028

Report ID: 1802521 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Seasonal Influenza Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Type A (H1N1)
        1.2.3 Type A (H3N2)
        1.2.4 Type B
    1.3 Market by Application
        1.3.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Pediatrics
        1.3.3 Adolescence
        1.3.4 Adults
        1.3.5 Elderly
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Seasonal Influenza Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global Seasonal Influenza Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Seasonal Influenza Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Seasonal Influenza Vaccines Sales by Region
        2.4.1 Global Seasonal Influenza Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales Seasonal Influenza Vaccines by Region (2023-2028)
    2.5 Global Seasonal Influenza Vaccines Revenue by Region
        2.5.1 Global Seasonal Influenza Vaccines Revenue by Region (2017-2022)
        2.5.2 Global Seasonal Influenza Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Seasonal Influenza Vaccines Sales by Manufacturers
        3.1.1 Global Top Seasonal Influenza Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Seasonal Influenza Vaccines in 2021
    3.2 Global Seasonal Influenza Vaccines Revenue by Manufacturers
        3.2.1 Global Seasonal Influenza Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Revenue in 2021
    3.3 Global Seasonal Influenza Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Seasonal Influenza Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Seasonal Influenza Vaccines Sales by Type
        4.1.1 Global Seasonal Influenza Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global Seasonal Influenza Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Seasonal Influenza Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global Seasonal Influenza Vaccines Revenue by Type
        4.2.1 Global Seasonal Influenza Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global Seasonal Influenza Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global Seasonal Influenza Vaccines Price by Type
        4.3.1 Global Seasonal Influenza Vaccines Price by Type (2017-2022)
        4.3.2 Global Seasonal Influenza Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Seasonal Influenza Vaccines Sales by Application
        5.1.1 Global Seasonal Influenza Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global Seasonal Influenza Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Seasonal Influenza Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global Seasonal Influenza Vaccines Revenue by Application
        5.2.1 Global Seasonal Influenza Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global Seasonal Influenza Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global Seasonal Influenza Vaccines Price by Application
        5.3.1 Global Seasonal Influenza Vaccines Price by Application (2017-2022)
        5.3.2 Global Seasonal Influenza Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Seasonal Influenza Vaccines Market Size by Type
        6.1.1 North America Seasonal Influenza Vaccines Sales by Type (2017-2028)
        6.1.2 North America Seasonal Influenza Vaccines Revenue by Type (2017-2028)
    6.2 North America Seasonal Influenza Vaccines Market Size by Application
        6.2.1 North America Seasonal Influenza Vaccines Sales by Application (2017-2028)
        6.2.2 North America Seasonal Influenza Vaccines Revenue by Application (2017-2028)
    6.3 North America Seasonal Influenza Vaccines Market Size by Country
        6.3.1 North America Seasonal Influenza Vaccines Sales by Country (2017-2028)
        6.3.2 North America Seasonal Influenza Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Seasonal Influenza Vaccines Market Size by Type
        7.1.1 Europe Seasonal Influenza Vaccines Sales by Type (2017-2028)
        7.1.2 Europe Seasonal Influenza Vaccines Revenue by Type (2017-2028)
    7.2 Europe Seasonal Influenza Vaccines Market Size by Application
        7.2.1 Europe Seasonal Influenza Vaccines Sales by Application (2017-2028)
        7.2.2 Europe Seasonal Influenza Vaccines Revenue by Application (2017-2028)
    7.3 Europe Seasonal Influenza Vaccines Market Size by Country
        7.3.1 Europe Seasonal Influenza Vaccines Sales by Country (2017-2028)
        7.3.2 Europe Seasonal Influenza Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Seasonal Influenza Vaccines Market Size by Type
        8.1.1 Asia Pacific Seasonal Influenza Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Seasonal Influenza Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific Seasonal Influenza Vaccines Market Size by Application
        8.2.1 Asia Pacific Seasonal Influenza Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Seasonal Influenza Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific Seasonal Influenza Vaccines Market Size by Region
        8.3.1 Asia Pacific Seasonal Influenza Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Seasonal Influenza Vaccines Market Size by Type
        9.1.1 Latin America Seasonal Influenza Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America Seasonal Influenza Vaccines Revenue by Type (2017-2028)
    9.2 Latin America Seasonal Influenza Vaccines Market Size by Application
        9.2.1 Latin America Seasonal Influenza Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America Seasonal Influenza Vaccines Revenue by Application (2017-2028)
    9.3 Latin America Seasonal Influenza Vaccines Market Size by Country
        9.3.1 Latin America Seasonal Influenza Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America Seasonal Influenza Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Seasonal Influenza Vaccines Market Size by Type
        10.1.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Seasonal Influenza Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Seasonal Influenza Vaccines Market Size by Application
        10.2.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Seasonal Influenza Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Seasonal Influenza Vaccines Market Size by Country
        10.3.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GlaxoSmithKline plc
        11.1.1 GlaxoSmithKline plc Corporation Information
        11.1.2 GlaxoSmithKline plc Overview
        11.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GlaxoSmithKline plc Recent Developments
    11.2 Sinovac Biotech Ltd
        11.2.1 Sinovac Biotech Ltd Corporation Information
        11.2.2 Sinovac Biotech Ltd Overview
        11.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sinovac Biotech Ltd Recent Developments
    11.3 Changsheng Bio-Technology
        11.3.1 Changsheng Bio-Technology Corporation Information
        11.3.2 Changsheng Bio-Technology Overview
        11.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Changsheng Bio-Technology Recent Developments
    11.4 Ccbio SA
        11.4.1 Ccbio SA Corporation Information
        11.4.2 Ccbio SA Overview
        11.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Ccbio SA Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Ccbio SA Recent Developments
    11.5 Aleph Biomedical
        11.5.1 Aleph Biomedical Corporation Information
        11.5.2 Aleph Biomedical Overview
        11.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Aleph Biomedical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Aleph Biomedical Recent Developments
    11.6 Sanofi
        11.6.1 Sanofi Corporation Information
        11.6.2 Sanofi Overview
        11.6.3 Sanofi Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Sanofi Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Sanofi Recent Developments
    11.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
        11.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
        11.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Overview
        11.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
    11.8 Dalian Hissen Bio-pharm
        11.8.1 Dalian Hissen Bio-pharm Corporation Information
        11.8.2 Dalian Hissen Bio-pharm Overview
        11.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Dalian Hissen Bio-pharm Recent Developments
    11.9 Abbott Laboratories
        11.9.1 Abbott Laboratories Corporation Information
        11.9.2 Abbott Laboratories Overview
        11.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Abbott Laboratories Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Abbott Laboratories Recent Developments
    11.10 Novartis International AG
        11.10.1 Novartis International AG Corporation Information
        11.10.2 Novartis International AG Overview
        11.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Novartis International AG Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Novartis International AG Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Seasonal Influenza Vaccines Industry Chain Analysis
    12.2 Seasonal Influenza Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Seasonal Influenza Vaccines Production Mode & Process
    12.4 Seasonal Influenza Vaccines Sales and Marketing
        12.4.1 Seasonal Influenza Vaccines Sales Channels
        12.4.2 Seasonal Influenza Vaccines Distributors
    12.5 Seasonal Influenza Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Seasonal Influenza Vaccines Industry Trends
    13.2 Seasonal Influenza Vaccines Market Drivers
    13.3 Seasonal Influenza Vaccines Market Challenges
    13.4 Seasonal Influenza Vaccines Market Restraints
14 Key Findings in The Global Seasonal Influenza Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Type A (H1N1)
    Table 3. Major Manufacturers of Type A (H3N2)
    Table 4. Major Manufacturers of Type B
    Table 5. Global Seasonal Influenza Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Seasonal Influenza Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Seasonal Influenza Vaccines Sales by Region (2017-2022) & (K Units)
    Table 8. Global Seasonal Influenza Vaccines Sales Market Share by Region (2017-2022)
    Table 9. Global Seasonal Influenza Vaccines Sales by Region (2023-2028) & (K Units)
    Table 10. Global Seasonal Influenza Vaccines Sales Market Share by Region (2023-2028)
    Table 11. Global Seasonal Influenza Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2017-2022)
    Table 13. Global Seasonal Influenza Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2023-2028)
    Table 15. Global Seasonal Influenza Vaccines Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Seasonal Influenza Vaccines Sales Share by Manufacturers (2017-2022)
    Table 17. Global Seasonal Influenza Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 19. Seasonal Influenza Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Seasonal Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines as of 2021)
    Table 22. Seasonal Influenza Vaccines Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Seasonal Influenza Vaccines Product Offered
    Table 24. Date of Manufacturers Enter into Seasonal Influenza Vaccines Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
    Table 27. Global Seasonal Influenza Vaccines Sales by Type (2023-2028) & (K Units)
    Table 28. Global Seasonal Influenza Vaccines Sales Share by Type (2017-2022)
    Table 29. Global Seasonal Influenza Vaccines Sales Share by Type (2023-2028)
    Table 30. Global Seasonal Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Seasonal Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Seasonal Influenza Vaccines Revenue Share by Type (2017-2022)
    Table 33. Global Seasonal Influenza Vaccines Revenue Share by Type (2023-2028)
    Table 34. Seasonal Influenza Vaccines Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Seasonal Influenza Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
    Table 37. Global Seasonal Influenza Vaccines Sales by Application (2023-2028) & (K Units)
    Table 38. Global Seasonal Influenza Vaccines Sales Share by Application (2017-2022)
    Table 39. Global Seasonal Influenza Vaccines Sales Share by Application (2023-2028)
    Table 40. Global Seasonal Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Seasonal Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Seasonal Influenza Vaccines Revenue Share by Application (2017-2022)
    Table 43. Global Seasonal Influenza Vaccines Revenue Share by Application (2023-2028)
    Table 44. Seasonal Influenza Vaccines Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Seasonal Influenza Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
    Table 47. North America Seasonal Influenza Vaccines Sales by Type (2023-2028) & (K Units)
    Table 48. North America Seasonal Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Seasonal Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
    Table 51. North America Seasonal Influenza Vaccines Sales by Application (2023-2028) & (K Units)
    Table 52. North America Seasonal Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Seasonal Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Seasonal Influenza Vaccines Sales by Country (2017-2022) & (K Units)
    Table 55. North America Seasonal Influenza Vaccines Sales by Country (2023-2028) & (K Units)
    Table 56. North America Seasonal Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Seasonal Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Seasonal Influenza Vaccines Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Seasonal Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Seasonal Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Seasonal Influenza Vaccines Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Seasonal Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Seasonal Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Seasonal Influenza Vaccines Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Seasonal Influenza Vaccines Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Seasonal Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Seasonal Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Seasonal Influenza Vaccines Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Seasonal Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Seasonal Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Seasonal Influenza Vaccines Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Seasonal Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Seasonal Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Seasonal Influenza Vaccines Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Seasonal Influenza Vaccines Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Seasonal Influenza Vaccines Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Seasonal Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Seasonal Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Seasonal Influenza Vaccines Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Seasonal Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Seasonal Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Seasonal Influenza Vaccines Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Seasonal Influenza Vaccines Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Seasonal Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Seasonal Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Seasonal Influenza Vaccines Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Seasonal Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Seasonal Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Seasonal Influenza Vaccines Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Seasonal Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Seasonal Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 106. GlaxoSmithKline plc Corporation Information
    Table 107. GlaxoSmithKline plc Description and Major Businesses
    Table 108. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. GlaxoSmithKline plc Recent Developments
    Table 111. Sinovac Biotech Ltd Corporation Information
    Table 112. Sinovac Biotech Ltd Description and Major Businesses
    Table 113. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Sinovac Biotech Ltd Recent Developments
    Table 116. Changsheng Bio-Technology Corporation Information
    Table 117. Changsheng Bio-Technology Description and Major Businesses
    Table 118. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Changsheng Bio-Technology Recent Developments
    Table 121. Ccbio SA Corporation Information
    Table 122. Ccbio SA Description and Major Businesses
    Table 123. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Ccbio SA Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Ccbio SA Recent Developments
    Table 126. Aleph Biomedical Corporation Information
    Table 127. Aleph Biomedical Description and Major Businesses
    Table 128. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Aleph Biomedical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Aleph Biomedical Recent Developments
    Table 131. Sanofi Corporation Information
    Table 132. Sanofi Description and Major Businesses
    Table 133. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Sanofi Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Sanofi Recent Developments
    Table 136. Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
    Table 137. Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Major Businesses
    Table 138. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
    Table 141. Dalian Hissen Bio-pharm Corporation Information
    Table 142. Dalian Hissen Bio-pharm Description and Major Businesses
    Table 143. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Dalian Hissen Bio-pharm Recent Developments
    Table 146. Abbott Laboratories Corporation Information
    Table 147. Abbott Laboratories Description and Major Businesses
    Table 148. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Abbott Laboratories Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Abbott Laboratories Recent Developments
    Table 151. Novartis International AG Corporation Information
    Table 152. Novartis International AG Description and Major Businesses
    Table 153. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Novartis International AG Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Novartis International AG Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. Seasonal Influenza Vaccines Distributors List
    Table 159. Seasonal Influenza Vaccines Customers List
    Table 160. Seasonal Influenza Vaccines Market Trends
    Table 161. Seasonal Influenza Vaccines Market Drivers
    Table 162. Seasonal Influenza Vaccines Market Challenges
    Table 163. Seasonal Influenza Vaccines Market Restraints
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Seasonal Influenza Vaccines Product Picture
    Figure 3. Global Seasonal Influenza Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Type A (H1N1) Product Picture
    Figure 4. Type A (H3N2) Product Picture
    Figure 5. Type B Product Picture
    Figure 6. Global Seasonal Influenza Vaccines Market Share by Application in 2021 & 2028
    Figure 7. Pediatrics
    Figure 8. Adolescence
    Figure 9. Adults
    Figure 10. Elderly
    Figure 11. Seasonal Influenza Vaccines Report Years Considered
    Figure 12. Global Seasonal Influenza Vaccines Sales 2017-2028 (K Units)
    Figure 13. Global Seasonal Influenza Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Seasonal Influenza Vaccines Revenue 2017-2028 (US$ Million)
    Figure 15. Global Seasonal Influenza Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Seasonal Influenza Vaccines Sales Market Share by Region (2017-2022)
    Figure 17. Global Seasonal Influenza Vaccines Sales Market Share by Region (2023-2028)
    Figure 18. North America Seasonal Influenza Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Seasonal Influenza Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Seasonal Influenza Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Seasonal Influenza Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Seasonal Influenza Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Seasonal Influenza Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Seasonal Influenza Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Seasonal Influenza Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Seasonal Influenza Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Seasonal Influenza Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Seasonal Influenza Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Seasonal Influenza Vaccines in the World: Market Share by Seasonal Influenza Vaccines Revenue in 2021
    Figure 30. Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Seasonal Influenza Vaccines Sales Market Share by Type (2017-2028)
    Figure 32. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2017-2028)
    Figure 33. Global Seasonal Influenza Vaccines Sales Market Share by Application (2017-2028)
    Figure 34. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2017-2028)
    Figure 35. North America Seasonal Influenza Vaccines Sales Market Share by Type (2017-2028)
    Figure 36. North America Seasonal Influenza Vaccines Revenue Market Share by Type (2017-2028)
    Figure 37. North America Seasonal Influenza Vaccines Sales Market Share by Application (2017-2028)
    Figure 38. North America Seasonal Influenza Vaccines Revenue Market Share by Application (2017-2028)
    Figure 39. North America Seasonal Influenza Vaccines Sales Share by Country (2017-2028)
    Figure 40. North America Seasonal Influenza Vaccines Revenue Share by Country (2017-2028)
    Figure 41. U.S. Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Seasonal Influenza Vaccines Sales Market Share by Type (2017-2028)
    Figure 44. Europe Seasonal Influenza Vaccines Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Seasonal Influenza Vaccines Sales Market Share by Application (2017-2028)
    Figure 46. Europe Seasonal Influenza Vaccines Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Seasonal Influenza Vaccines Sales Share by Country (2017-2028)
    Figure 48. Europe Seasonal Influenza Vaccines Revenue Share by Country (2017-2028)
    Figure 49. Germany Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. France Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Seasonal Influenza Vaccines Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Seasonal Influenza Vaccines Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Seasonal Influenza Vaccines Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Seasonal Influenza Vaccines Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Seasonal Influenza Vaccines Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Seasonal Influenza Vaccines Revenue Share by Region (2017-2028)
    Figure 60. China Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. India Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Seasonal Influenza Vaccines Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Seasonal Influenza Vaccines Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Seasonal Influenza Vaccines Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Seasonal Influenza Vaccines Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Seasonal Influenza Vaccines Sales Share by Country (2017-2028)
    Figure 75. Latin America Seasonal Influenza Vaccines Revenue Share by Country (2017-2028)
    Figure 76. Mexico Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Seasonal Influenza Vaccines Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Seasonal Influenza Vaccines Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Seasonal Influenza Vaccines Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Seasonal Influenza Vaccines Revenue Share by Country (2017-2028)
    Figure 85. Turkey Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Seasonal Influenza Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 88. Seasonal Influenza Vaccines Value Chain
    Figure 89. Seasonal Influenza Vaccines Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline plc
Sinovac Biotech Ltd
Changsheng Bio-Technology
Ccbio SA
Aleph Biomedical
Sanofi
Jiangsu Simcere Vaxtec Bio-pharmaceutical
Dalian Hissen Bio-pharm
Abbott Laboratories
Novartis International AG
Frequently Asked Questions
Seasonal Influenza Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Seasonal Influenza Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Seasonal Influenza Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Insect Media

Insect Media market is segmented by Type and by Application. Players, stakeholders, and other par ... Read More

Instrument Panel

Instrument Panel market is segmented by Type and by Application. Players, stakeholders, and other ... Read More

Insulated Paint

Insulated Paint market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More